Pieris Pharmaceuticals Inc. (PIRS) Stock Price Is Rising, Here is What You Need to Know
Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology company committed to the discovery and development of Anticalinbased drugs that target validated disease pathways, announced that it is part of a multi-program research collaboration and license agreement with Genentech. PIRS stock price surged immensely adjacent to the news. Pieris Pharmaceuticals Inc. (PIRS) shares were rising 44.86% […]